Shopping Cart
Remove All
Your shopping cart is currently empty
ALM301 is a highly specific, orally active AKT inhibitor that acts on AKT1 (IC50: 0.13 μM), AKT2 (IC50: 0.09 μM) and AKT3 (IC50: 2.75 μM). ALM301 inhibits AKT phosphorylation in vitro and has a regulatory effect on downstream signalling. ALM301 exhibits inhibitory effects on cancer cell proliferation and tumor growth.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,370 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,790 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,890 | 8-10 weeks | 8-10 weeks |
| Description | ALM301 is a highly specific, orally active AKT inhibitor that acts on AKT1 (IC50: 0.13 μM), AKT2 (IC50: 0.09 μM) and AKT3 (IC50: 2.75 μM). ALM301 inhibits AKT phosphorylation in vitro and has a regulatory effect on downstream signalling. ALM301 exhibits inhibitory effects on cancer cell proliferation and tumor growth. |
| Targets&IC50 | Akt3:2.75 μM, AKT1:0.13 μM, Akt2:0.09 μM |
| Molecular Weight | 415.48 |
| Formula | C25H25N3O3 |
| Cas No. | 1313439-71-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.